Early brain development, treatable epilepsy, and misdiagnosed cerebral palsy — what parents and doctors need to know, backed by clinical case studies from paediatric neurology specialists.
Insights from a pediatric neurology masterclass on treatable conditions, brain plasticity, and when to refer early
The brain of a newborn is one of the most extraordinary things in nature — and one of the most vulnerable. In a recent masterclass on treatable conditions in pediatric neurology, three leading specialists shared decades of clinical insight that challenges how we think about child development, epilepsy, and the often-overlooked conditions hiding behind a "cerebral palsy" diagnosis.
Here is what stood out.
The First Five Years Are Not Just Important — They're Everything
82% of brain development happens before age five. That number deserves to be read twice.
The brain's plasticity — its ability to form new connections, rewire itself, and recover from damage — is at its peak in the first year of life, plateaus by age seven or eight, and steadily declines from there. This isn't a gentle slope. It's a steep cliff.
What drives plasticity? Quite a lot: sensory stimulation, physical exercise, quality sleep, loving relationships, good nutrition, and even a healthy level of stress (bordering on boredom is actually ideal for learning). What damages it? Chronic drug exposure, emotional neglect, malnutrition, and unstimulating environments.
One striking visual from the lecture compared brain scans of institutionalised children with those raised in loving homes. The difference in active brain circuitry was stark and sobering.
The practical implication: Early intervention is not a "nice to have" — it is the single most powerful tool available. The earlier a problem is corrected, the better the brain can compensate and build new circuits. Waiting costs far more than acting.
🏨 Exclusive Hotel Deals
Compare top-rated hotels, discover seasonal offers, and book your ideal stay at unbeatable prices.
Explore Hotels & Accommodations →Repetition Is How the Brain Learns — Literally
Think of learning as road-building. You teach a child something once, they forget most of it within a day. Teach it again — the road gets slightly wider. Teach it with passion, focus, and emotion — it becomes a highway. Once a neural highway is laid down, it tends to stay for life.
This is also the mechanism behind physiotherapy, speech therapy, and all rehabilitation. Doing something again and again, in a focused and emotionally engaged environment, physically changes the brain. That is not metaphor. It is neuroscience.
Sleep, exercise, and meditation all support this process. Even 20 minutes of walking before a study session measurably improves brain activation. Children who sleep 9–11 hours retain far more than those who stay up late cramming.
Vitamins That Can Change a Child's Life
Some of the most powerful treatments in pediatric neurology are not sophisticated drugs. They are vitamins.
Pyridoxine (Vitamin B6) deficiency can cause intractable seizures from the newborn period. A trial dose of pyridoxine can transform an unresponsive infant with relentless epilepsy into a child who develops normally — if identified early enough. It must be continued lifelong, and the dose is higher in the newborn period.
Biotin deficiency presents with regression of milestones, skin rashes, white matter changes on MRI, and a peculiar acidotic breathing pattern. Treatment: 5–10 mg of biotin daily, lifelong. Dramatic improvement is the norm when caught in time.
Biotin-thiamine metabolic disorders can masquerade as mitochondrial disease — with basal ganglia changes, regression after an infection, and alarming MRI findings. A case shared in the lecture involved a toddler who started walking again within three days of empirical treatment while genetic results were still pending.
Vitamin B12 deficiency is underdiagnosed and underdiscussed. It can present as low mood, poor attention, neuropathy, gait disturbance, and in severe cases, progressive cognitive decline indistinguishable from a neurodegenerative disease. One case involved a 10-year-old who had stopped attending school due to a staggering gait — her B12 was 92. She was back in school within days of treatment.
The takeaway: B12 and homocysteine should be checked as a matter of routine in any child presenting with neurological symptoms. It is cheap, treatable, and the consequences of missing it are severe.
Not Everything That Looks Like Cerebral Palsy Is Cerebral Palsy
Between 10 and 18% of children treated as cerebral palsy (CP) have a different diagnosis entirely — one that, if identified, could be specifically and meaningfully treated.
Three cases from the lecture illustrate this:
- A child with dystonia and a normal MRI who was started on levodopa (L-dopa) and began walking independently. Diagnosis: dopa-responsive dystonia — a genetic condition that responds dramatically to treatment.
- A child with spasticity and brisk reflexes, treated for years as CP, whose spinal MRI revealed an atlantoaxial dislocation compressing the cervical cord. After decompressive surgery, he walked with support for the first time.
- A child with a large tongue, coarse facial features, and motor delay whose TSH came back consistent with congenital hypothyroidism — a condition entirely treatable with thyroid hormone replacement, had it been caught earlier.
Red flags that a child may not have CP:
- Normal MRI despite a CP diagnosis
- No documented perinatal insult (cried at birth, discharged with mother, feeding established normally)
- Positive family history or an affected sibling
- Consanguineous parents
- Hypotonia with dysmorphic features
- Regression of milestones rather than a static picture
If any of these are present, it is worth pausing and investigating further before settling into a long-term rehabilitation-only plan.
Epilepsy: The Drug Ladder Has a Ceiling
The evidence on anti-seizure medications is clarifying — and somewhat humbling. The first drug works for about 50% of patients. The second drug helps an additional 13%. The third? Roughly 1%. Beyond that, the benefit drops to near zero.
This is not a reason for pessimism. It is a reason to change strategy earlier.
For children with drug-resistant epilepsy — defined as failure to control seizures with two appropriately chosen medications — the chance that a third drug will work is under 10%. The chance that epilepsy surgery will significantly reduce or eliminate seizures? Anywhere from 50% to 95%, depending on the type.
Yet children in India routinely arrive at specialist centres having tried nine or ten medications over years, with daily seizures and measurable cognitive decline. Every month of uncontrolled seizures in a growing brain carries a cost.
Epilepsy Surgery: More Effective, Safer, and More Available Than You May Think
Epilepsy surgery is not a last resort. For the right patient, it is the best option.
In a dedicated pediatric epilepsy surgery programme at SRCC Children's Hospital in Mumbai — the first and only such centre in India — 90% of patients who underwent curative surgery were seizure-free or had no disabling seizures at their last follow-up. Across 100 surgeries, there was zero mortality and only one case of an unexpected permanent neurological deficit.
The surgery works by identifying and removing (or disconnecting) the brain tissue generating the seizures — the epileptic network. This is mapped meticulously before the operation using prolonged video-EEG, epilepsy-protocol MRI, neuropsychology, and in some cases PET scans, depth electrode recordings, and functional MRI. No surgeon touches the brain without a concordant hypothesis about where the seizures are coming from.
For children whose seizures cannot be cured — for example, those with bilateral brain malformations — palliative procedures like corpus callosotomy can eliminate the dangerous falls (drop attacks) that injure them daily, restoring quality of life even without complete seizure freedom.
The 2022 international guidelines now recommend that any patient with a surgically remediable epilepsy should be offered surgery evaluation — not after drug failure, but as soon as the condition is identified.
Quick Reference: Practical Pearls from the Masterclass
- Paediatric migraine: First-line preventive treatment is flunarizine, not propranolol or valproate. Allow 10–15 days before assessing response. Advise about weight gain and give as a night dose.
- Topiramate side effect: Unexplained fever in a child on topiramate — cut the dose and increase fluids. Temperature dysregulation is well documented and frequently missed.
- Gabapentin: An excellent drug for dystonia and neuropathic pain in children, including those with CP as they grow older.
- Tuberous sclerosis: If a young child presents with seizures, undress them. Look for ash-leaf macules and shagreen patches. If present, early treatment with vigabatrin — even before clinical seizures begin — may prevent epileptic encephalopathy.
- Genetics: Reports now come back within a month, sometimes faster. More importantly, knowing the gene guides drug choice. Certain genes mean certain drugs must be avoided; others point toward ketogenic diet or specific precision therapies.
The Bigger Picture
Governments spend the majority of their education and health budgets on adolescence and adulthood — scholarships, university, vocational training. The period when the brain is most responsive to investment, the first five years of life, receives comparatively little.
Families, clinicians, and systems all have a role to play in reversing this. The science is unambiguous: early diagnosis, early treatment, and a stimulating, loving environment produce better outcomes than anything that can be done later. Not just marginally better — dramatically better.
The good news is that treatable conditions, caught in time, can genuinely transform lives. The cases in this masterclass are proof of that.
This post is adapted from a continuing medical education session on treatable conditions in paediatric neurology, featuring presentations by specialists in paediatric neurology, complex epileptology, and paediatric neurosurgery: